Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|February 4, 1991
[Nephrotoxicity of gentamycin used in hepatic and biliary diseases]A Debska-Slizień, B Rutkowski
Polskie Archiwum Medycyny Wewnetrznej|September 1, 1994
[Effect of human recombinant erythropoietin (r-EPO) on behavior of iron status parameters in patients with chronic renal failure treated with dialysis]A Debska-Slizień, B Biedunkiewicz, B Rutkowski
Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina|January 1, 1994
Importance of iron status monitoring during erythropoietin treatment in uremic predialysis patientsB Rutkowski, A Debska-Slizień, B Biedunkiewicz, et al.
The International Journal of Artificial Organs|January 8, 2005
Erythrocyte metabolism during renal anemia treatment with recombinant human erythropoietinA Debska-Slizień, A Owczarzak, W Lysiak-Szydłowska, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 1, 1994
[Effect of treatment with erythropoietin (r-EPO) on hemodynamics of the cardiovascular system in patients with chronic renal failure (c.r.f.)]A Kubasik, A Debska-Slizień, M Dudziak, et al.
Transplantation Proceedings|March 1, 2006
One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimusA Chamienia, B Biedunkiewicz, E Król, et al.
Transplantation Proceedings|November 18, 2009
Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complexA Tarasewicz, A Debska-Slizień, J Konopa, et al.
The International Journal of Artificial Organs|February 27, 2003
Plasma carnitine profile during chronic renal anemia treatment with recombinant human erythropoietinA Debska-Slizień, A Owczarzak, D Kunicka, et al.
Polskie Archiwum Medycyny Wewnetrznej|November 1, 1995
[Does erythropoietin treatment influence the lipid status of patients on maintenance hemodialysis?]E Król, A Debska-Slizień, B Biedunkiewicz, et al.
Pageof 2